Literature DB >> 12884863

Pre-TCR signaling regulates IL-7 receptor alpha expression promoting thymocyte survival at the transition from the double-negative to double-positive stage.

Cesar Trigueros1, Katsuto Hozumi, Bruno Silva-Santos, Ludovica Bruno, Adrian C Hayday, Michael J Owen, Daniel J Pennington.   

Abstract

The pre-T cell receptor (pre-TCR) and IL-7 receptor (IL-7R) are critical mediators of survival, proliferation and differentiation in immature thymocytes. Here we show that pre-TCR signaling directly maintains IL-7Ralpha expression as developing thymocytes undergo beta-selection. Inhibition of IL-7/IL-7R signaling in (CD44-CD25-) DN4 cells results in decreased generation of double-positive thymocytes due to increased death of rapidly proliferating beta-selected cells. Thus, we identify a mechanism by which pre-TCR signaling controls the selective survival of TCRbeta+ thymocytes, and define a further stage of T cell differentiation in which signaling from a TCR regulates the ability of that cell to respond to cytokine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12884863     DOI: 10.1002/eji.200323831

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

1.  Targeted Sos1 deletion reveals its critical role in early T-cell development.

Authors:  Robert L Kortum; Connie L Sommers; Clayton P Alexander; John M Pinski; Wenmei Li; Alex Grinberg; Jan Lee; Paul E Love; Lawrence E Samelson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-11       Impact factor: 11.205

2.  Distinct roles of IL-7 and stem cell factor in the OP9-DL1 T-cell differentiation culture system.

Authors:  Hongfang Wang; L Jeanne Pierce; Gerald J Spangrude
Journal:  Exp Hematol       Date:  2006-12       Impact factor: 3.084

3.  Histone Deacetylase 3 Is Required for Efficient T Cell Development.

Authors:  Kristy R Stengel; Yue Zhao; Nicholas J Klus; Jonathan F Kaiser; Laura E Gordy; Sebastian Joyce; Scott W Hiebert; Alyssa R Summers
Journal:  Mol Cell Biol       Date:  2015-08-31       Impact factor: 4.272

4.  Interleukin-7 supports survival of T-cell receptor-β-expressing CD4(-) CD8(-) double-negative thymocytes.

Authors:  Juan Xiong; Brooks L Parker; Stacy L Dalheimer; Thomas M Yankee
Journal:  Immunology       Date:  2013-04       Impact factor: 7.397

5.  Sustained expression of pre-TCR induced beta-catenin in post-beta-selection thymocytes blocks T cell development.

Authors:  Mai Xu; Archna Sharma; M Zulfiquer Hossain; David L Wiest; Jyoti Misra Sen
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

Review 6.  Critical roles of the PI3K/Akt signaling pathway in T cell development.

Authors:  Marisa M Juntilla; Gary A Koretzky
Journal:  Immunol Lett       Date:  2008-01-10       Impact factor: 3.685

7.  A role for apoptosis-inducing factor in T cell development.

Authors:  Hridesh Banerjee; Abhishek Das; Smita Srivastava; Hamid R Mattoo; Krishnamurthy Thyagarajan; Jasneet Kaur Khalsa; Shalini Tanwar; Deepika Sharma Das; Subeer S Majumdar; Anna George; Vineeta Bal; Jeannine M Durdik; Satyajit Rath
Journal:  J Exp Med       Date:  2012-08-06       Impact factor: 14.307

8.  IL-7 receptor signals inhibit expression of transcription factors TCF-1, LEF-1, and RORgammat: impact on thymocyte development.

Authors:  Qing Yu; Batu Erman; Jung-Hyun Park; Lionel Feigenbaum; Alfred Singer
Journal:  J Exp Med       Date:  2004-09-13       Impact factor: 14.307

9.  The loss of PTEN allows TCR alphabeta lineage thymocytes to bypass IL-7 and Pre-TCR-mediated signaling.

Authors:  Thijs J Hagenbeek; Marianne Naspetti; Fabrice Malergue; Fabien Garçon; Jacques A Nunès; Kitty B J M Cleutjens; Jan Trapman; Paul Krimpenfort; Hergen Spits
Journal:  J Exp Med       Date:  2004-09-27       Impact factor: 14.307

10.  The RNA-Binding Proteins Zfp36l1 and Zfp36l2 Enforce the Thymic β-Selection Checkpoint by Limiting DNA Damage Response Signaling and Cell Cycle Progression.

Authors:  Katharina U Vogel; Lewis S Bell; Alison Galloway; Helena Ahlfors; Martin Turner
Journal:  J Immunol       Date:  2016-08-26       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.